The chronic-pain psilocybin mechanism paper and cognition systematic review will conclude 'insufficient evidence / more research needed' rather than endorse clinical rollout.

Two new scientific works — one examining how psilocybin might affect chronic pain in the body, and one reviewing what we know about psilocybin and thinking/cognition — will both stop short of telling doctors to use psilocybin clinically. Instead, they'll call for more studies. This is the standard conclusion in early-stage science, and it signals we're still years away from evidence strong enough to guide treatment.

These are translational/review works, not efficacy trials; mechanistic literature reliably urges caution. Falsifiable against the published conclusion text of the specific papers referenced.